Dyspamet Suspension
Cimetidine
200mg/5ml
SmithKline & French Labs. Ltd.
| Pack size | 100ml Bottle |
|---|---|
| Dispensing mode | POM |
| Source | UK |
| Agent | GULF DRUG EST. |
| Retail Price | 30.50 AED |
Available as:
Indications
Dyspamet Suspension is used for:
Heartburn, Dyspepsia, Peptic ulcers, Benign gastric and duodenal ulceration, Gastro-oesophageal reflux disease, Zollinger-Ellison syndrome, Pancreatic insufficiency
Adult Dose
Intravenous
Benign gastric and duodenal ulceration
Adult: Intermittent infusion: 300 mg 6-8 hrly infused over 15-20 min. Max: 2400 mg/day.
Continuous infusion: 37.5 mg/hr (900 mg/day). A 150 mg IV loading dose may be given in patients requiring rapid elevation of gastric pH.
Zollinger-Ellison syndrome
Adult: Intermittent infusion: 300 mg 6-8 hrly infused over 15-20 min. Max: 2400 mg/day.
Continuous infusion: 37.5 mg/hr (900 mg/day). A 150 mg IV loading dose may be given in patients requiring rapid elevation of gastric pH.
Child Dose
Renal Dose
Renal Impairment
CrCl<30 mL/min
300 mg IV/IO q12hr
Prevention of upper GI bleeding: 25 mg/hour continuous IV infusion
Administration
IV Preparation
Solution
Injections: in 5% sodium bicarbonate injection, NS, D5W, D10W or LR to a volume of 20 mL
Infusions: 300 mg in 100 mL D5W
IV Administration
Slow direct IV injection over 5 min or more after dilution to a total of 20 mL with compatible diluent (NS), OR
Intermittent IV infusion over 15 to 20 min in at least 50 mL of compatible diluent, OR
Continuous IV infusion in 100 to 1000 mL of compatible diluent over 24 hr
Contra Indications
Hypersensitivity, lactation.
Precautions
Impaired renal and hepatic function. Age >50 yr; CV impairment. Pregnancy.
Lactation: enters breast milk/not recommended
Pregnancy-Lactation
Pregnancy Category: B
Lactation: enters breast milk/not recommended
Interactions
Reduces absorption of dasatinib, ketoconazole, itraconazole and posaconazole. May increase serum levels of phenytoin, theophylline, lidocaine, hydroxyzine and oral anticoagulants. Absorption may be reduced by antacids. Decreased bioavailability w/ metoclopramide, sucralfate or propantheline. May potentiate the myelosuppressive effects (e.g. agranulocytosis, neutropenia) of myelosuppressive drugs (e.g. antimetabolites, alkylating agents) or therapies (e.g. radiation).
Adverse Effects
Side effects of Cimetidine :
1-10%
Headache (2.1%), Dizziness (1%), Somnolence (1%), Gynecomastia (0.3-4%)
Frequency Not Defined
Confusion (elderly), Impotence, Diarrhea, Nausea, Vomiting
Mechanism of Action
Cimetidine competitively inhibits histamine at H2-receptors of the gastric parietal cells resulting in decreased gastric acid secretion, gastric volume and hydrogen ion concentration. It is also used in patients w/ pancreatic insufficiency to reduce the breakdown of pancreatic enzyme supplements.
Note
Dyspamet 200mg/5ml Suspension manufactured by SmithKline & French Labs. Ltd.. Its generic name is Cimetidine. Dyspamet is availble in United Arab Emirates.
Farmaco UAE drug index information on Dyspamet Suspension is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.